Li et al. [45] reported that METTL3 promoted colorectal cancer progression through an m6A-IGF2BP2-dependent mechanism, while Deng et al. [46] reported that METTL3 inhibited the proliferation and migration of colorectal cancer cells through the p38/ERK pathway. Here, IGF2BP2 is linked to colorectal cancer.